Plain-English translation of NCT06755008 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying induced pluripotent stem cells (iPS cells) — special cells that can become any cell type in the body — to see if they can repair damaged lung tissue in people with COPD. This is early-stage research happening in the laboratory, not a treatment being given to patients yet. The study will compare lung tissue from three groups: people with COPD, smokers without COPD, and healthy non-smokers.
COPD damages the delicate lining of the airways, causing too much mucus buildup and breathing problems. Researchers have noticed that certain repair cells are missing in COPD lungs. This study aims to understand whether stem cells could one day help regenerate and restore these damaged tissues, offering a completely new approach to treating the disease.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will have a small tissue sample taken from your lungs during a bronchoscopy — a procedure your lung doctor is already planning for your medical care. Researchers will then use this sample in the laboratory to grow and study stem cells, testing whether they can repair damaged lung tissue in a lab setting. This is not a treatment; the study is purely research-based and happens entirely in the lab after your sample is collected.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France